WhitTier Trust Company’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

WhitTier Trust Company’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12,066	Closed	-$9K	–	1010
2020 Q4	$9K	Sell	12,066 -1,081	-8%	-$2.3K	﹤0.01%	850
2020 Q3	$30K	Sell	13,147 -120	-0.9%	-$343	﹤0.01%	682
2020 Q2	$48K	Sell	13,267 -14,440	-52%	-$52.1K	﹤0.01%	583
2020 Q1	$105K	Sell	27,707 -4,007	-13%	-$13.2K	0.01%	449
2019 Q4	$95K	Buy	+31,714	New	+$82.5K	0.01%	498

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return

WAM

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

WhitTier Trust Company's BMY.RT Position: Q1 2021 in Review

WhitTier Trust Company sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 12,066 shares — an estimated $9K sold.

WhitTier Trust Company first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $105K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

WhitTier Trust Company reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
WhitTier Trust Company sold 12,066 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $9K.
WhitTier Trust Company first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
WhitTier Trust Company's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $105K in Q1 2020.
12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on WhitTier Trust Company's 13F filing for Q1 2021, filed 26 Apr 2021.